Long–term efficacy of Chelsea drug may pose problems for FDA
(Reuters) – A treatment developed by Chelsea Therapeutics International Ltd for a rare type of low blood pressure is presenting problems for U.S. drug reviewers at the U.S. Food and Drug Administration. A review, posted on the FDA's website on Friday, … Read more on Reuters

Long–Term Varenicline Treatment Supports Tobacco Abstinence in People With …
Jan. 7, 2014 — Extended treatment with the smoking cessation drug varenicline (Chantix) significantly improved the ability of individuals with serious mental illness to maintain abstinence from tobacco after a standard 12-week course of treatment. In … Read more on Science Daily (press release)

FDA approves new drug for treatment of type 2 diabetes
High blood sugar levels can lead to serious short-term and long-term health issues, such as nerve and kidney damage, blindness and heart disease. Farxiga, a sodium-glucose co-transporter 2 inhibitor (SGLT2), works by preventing the kidney from … Read more on Medical News Today

Doesn't ADD Up: Doctors behind ADHD study question drug treatment
Behavioral therapy, meanwhile, focuses on developing a child's long-term academic and social skills. According to psychologist Ruth Hughes of the advocacy group Children and Adults With Attention-Deficit/Hyperactivity Disorder, medication may make a … Read more on RT